Work

Selective ROCK2 inhibitor reverses experimental chronic graft-versus-host disease via concurrent regulation of STAT3/STAT5 phosphorylation (TRAN1P.933)

Year: 2015

Type: conference-abstract

Source: The Journal of Immunology

DOI: 10.4049/jimmunol.194.supp.140.15

Authors: Alexandra Zanin-Zhorov, Ryan Flynn, Leo Luznik, melanie Nyuydzefe, Angela Panoskaltsis-Mortari, Jing Du, Katelyn Goodman, Jonathan Weiss, Wei Chen, Jonathan Serody, Kelli MacDonald, Geoffrey Hill, John O'Shea, Samuel Waksal, Bruce Blazar

Institutions: Kadmon Corporation (United States), University of Minnesota, Johns Hopkins University, Johns Hopkins Medicine, University of North Carolina at Chapel Hill, UNC Lineberger Comprehensive Cancer Center, QIMR Berghofer Medical Research Institute, National Institutes of Health

Language: English

Topic: Hematopoietic Stem Cell Transplantation

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2620176696

Cites:

Cited by: 1

Related to: 10